Pressroom: Media Coverage

Showing 441 - 460 of 598 news items

2012

US Indoor Tanning Tax Having Mixed Effects

A new survey found that only a handful of indoor tanning salons reported a drop in clients after a 2010 federal excise tax was implemented to deter customers from using indoor tanning services. Steven Wang, head of dermatology in Basking Ridge, was quoted.

January 19, 2012
Cancer-Fighting Food Tactics

Registered dietitian Margaret Ziegler offered tips and nutrition information for people living with cancer. She said that there is no “one-size-fits-all” approach because the experience of cancer is so individualized and every person with cancer has a unique experience.

January 16, 2012
Cancer Barbie: Backers Seeking Bald Doll to Help Sick Kids Come to Terms with Hair Loss

Two women whose lives have been touched by cancer started an online campaign urging toy manufacturer Mattel to produce a bald Barbie doll to help kids cope with hair loss. Child psychiatrist and pediatrician Abraham Bartell was quoted.

January 12, 2012
New Prostate Cancer Gene Mutation Discovered

Surgery Chair Peter Scardino commented on the discovery of a new gene mutation linked to a higher risk of developing hereditary prostate cancer. Dr. Scardino said that with further research, the new gene mutation might be one of many in a panel that clinicians could screen for in order to determine which men should receive prostate cancer testing at a younger age.

January 11, 2012
Cycling for Rare Cancers

Dave Linn, co-founder of Cycle for Survival, talked about his wife, Memorial Sloan Kettering patient Jennifer Goodman Linn, whose tireless efforts to raise awareness for rare cancers led to the establishment of one of the world’s fastest-growing athletic fundraising events. Cycle for Survival has raised more than $12 million in support of lifesaving research on rare cancers at Memorial Sloan Kettering.

January 5, 2012

2011

Memorial Sloan Kettering’s Paul Chapman, MD, Selected for the “Best of 2011” List

Esquire Magazine named Memorial Sloan Kettering’s Paul Chapman as one of the 77 reasons to celebrate in 2011 for his work with the drug vemurafenib. In clinical trials for treating melanoma, the drug proved so successful that the trial was halted early, so all patients could benefit from the therapy.

December 28, 2011
Avastin Passes Test in Delaying Ovarian Cancer

Memorial-Sloan Kettering’s Carol Aghajanian discussed a study that showed that for women with advanced cases of ovarian cancer, the drug Avastin adds about four months to the time it takes for the cancer to worsen.

December 28, 2011
Bringing Nutrition to the Fight Against Cancer

Through a partnership with Memorial Sloan Kettering’s Immigrant Health & Disparities Service, the Food Bank for NYC has been able to link hospitals with local food pantries to ensure that people fighting cancer have the necessary food to help win the battle.

December 27, 2011
Winning the War on Cancer (Quietly)

Memorial Sloan Kettering’s Clifford Hudis discussed advances in cancer screening, diagnosis, and treatment since President Richard Nixon declared a “war on cancer” 40 years ago.

December 25, 2011
The War on Cancer

Memorial Sloan Kettering biostatistician Ann Zauber commented on the phrase, “war on cancer,” which was declared 40 years ago when President Richard Nixon signed the National Cancer Act. Dr. Zauber said we are winning the war and she likes the metaphor.

December 23, 2011
Montclair Man's Bone Marrow Donation Pays Forward a Gift His Son Received

A grateful father was inspired to donate peripheral blood stem cells for a sick child after an anonymous donor saved the life of his own son, who received a bone marrow transplant at Memorial Sloan Kettering when he was just 14 months old. Memorial Sloan Kettering’s Richard O’Reilly was interviewed.

December 22, 2011
Targeted Drug Side Effects Add to Cancer Costs

Painful rashes and other skin-related side effects of newer targeted cancer drugs may increase treatment costs, according to a recent study published by Memorial Sloan Kettering dermatologist Mario Lacouture.

December 21, 2011
Mammogram Rates Lower for Mexican Women in US

Epidemiologist Elena Elkin discussed a study that found that Mexican women in the US are less likely to get mammograms than white women, black women and other Latinas.

December 20, 2011
A Harvard Doctor's Startup Trains Hospitals to Rehab Cancer Survivors

Dr. Julie Silver, a breast cancer survivor, co-founded a company to help hospitals and rehab centers tailor rehab programs to cancer patients. Memorial Sloan Kettering’s Michael Stubblefield discussed Memorial Sloan Kettering’s Rehabilitation Service, which has grown from two therapists to 18 as its focus has broadened to address the comprehensive rehab needs of cancer patients.

December 16, 2011
Tex Visits with Kids

Mark Teixeira of the New York Yankees paid a special holiday visit to the Department of Pediatrics. Memorial Sloan Kettering’s Richard O’Reilly was interviewed.

December 15, 2011
When Care Is Worth It, Even if End Is Death - New York Times Essay

Memorial Sloan Kettering epidemiologist Peter Bach wrote an essay about the amount of money spent on providing care to patients who may die.

December 13, 2011
Early Hodgkin Lymphoma Patients Can Skip Radiation Therapy, Study Finds

Memorial Sloan Kettering’s David Straus discussed an editorial he wrote in response to a study that found that patients with early stages of Hodgkin lymphoma would benefit from chemotherapy alone because adding radiation leads to higher death rates.

December 11, 2011
Two Drugs Appear to Delay Progression of Breast Cancer

Memorial Sloan Kettering’s Clifford Hudis commented on studies presented at the San Antonio Breast Cancer Symposium that showed that two new combinations of drugs significantly slowed the progression of tumors among women fighting metastatic breast cancer. Larry Norton also commented on the studies in The Washington Post.

December 8, 2011
Prostate Cancer Hormonal Therapy Cuts Deaths

Memorial Sloan Kettering researcher Behfar Ehdaie discussed findings that showed that hormone-targeted therapy cuts the overall risk of death for men with aggressive prostate cancer.

December 6, 2011
Staying the Course

Memorial-Sloan Kettering’s Andrew Zelenetz discussed maintenance therapy. Typically, cancer treatments are administered for a limited time to stabilize a cancer and its symptoms or to put it into remission, and treatment resumes only if the cancer gets worse or comes back. Maintenance therapy fights off any cancer cells that might remain in the body after the initial therapy.

December 5, 2011